Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery
NCT02590497 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2018-01-31
Summary
This pilot clinical trial studies the correlation between the genetics and brain images of patients with newly diagnosed glioblastoma before surgery. The genetic characteristics of a tumor are an important way to predict how well it will respond to treatment. Imaging, using magnetic resonance imaging (MRI), takes detailed pictures of organs inside the body, and may also provide information that helps doctors predict how brain tumors will respond to treatment. If MRI can provide doctors with similar information about the tumor as the tumor's genes, it may be able to be used to predict tumor response in patients whose tumors cannot be reached by surgery or biopsy to get tissue samples.
Conditions
Interventions
- PROCEDURE
-
Diffusion Weighted Imaging
Undergo diffusion weighted MRI
- DRUG
-
Gadolinium
Undergo gadolinium-enhanced MRI
- OTHER
-
Laboratory Biomarker Analysis
Tissue genetic analysis
- PROCEDURE
-
Magnetic Resonance Imaging
Undergo gadolinium-enhanced MRI
- PROCEDURE
-
Magnetic Resonance Imaging
Undergo 3D volumetric T1-weighted sequence
- PROCEDURE
-
Magnetic Resonance Imaging
Undergo FLAIR sequence
- PROCEDURE
-
Perfusion Magnetic Resonance Imaging
Undergo perfusion MRI
Sponsors & Collaborators
-
Ohio State University Comprehensive Cancer Center
lead OTHER
Principal Investigators
-
Pierre Giglio, MD · Ohio State University Comprehensive Cancer Center
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-03-20
- Primary Completion
- 2017-10-26
- Completion
- 2017-10-26
More Related Trials
-
Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma
NCT06090903 ·Status: RECRUITING ·Phase: NA
-
MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma
NCT00756106 ·Status: TERMINATED ·Phase: NA
-
Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors
NCT00005083 ·Status: WITHDRAWN ·Phase: PHASE2
-
Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma
NCT04540107 ·Status: RECRUITING ·Phase: PHASE1
-
Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients
NCT02095353 ·Status: TERMINATED
-
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
NCT00870129 ·Status: RECRUITING ·Phase: NA
-
Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
NCT00589095 ·Status: TERMINATED
-
Magnetic Resonance Imaging in Evaluating Response to RadiationTherapy in Patients With High Grade Glioma
NCT01018329 ·Status: COMPLETED ·Phase: NA
-
68Ga-citrate PET/MR Imaging for Glioma
NCT03335280 ·Status: TERMINATED
-
DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem Glioma
NCT00899834 ·Status: COMPLETED
-
Biomarkers for Prognosis of Glioblastoma (GBM)
NCT01493219 ·Status: COMPLETED
-
Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors
NCT00659126 ·Status: TERMINATED ·Phase: PHASE2
-
Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas
NCT00274755 ·Status: COMPLETED ·Phase: PHASE2
-
Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers
NCT05541042 ·Status: NOT_YET_RECRUITING
-
Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of Incident WHO II and III Grade Gliomas.
NCT04461002 ·Status: COMPLETED
-
Comparative 2-D Tumor Analysis in Familial Gliomas
NCT00125710 ·Status: COMPLETED
-
Non-invasive Glioma Characterization Through Molecular Imaging
NCT03684109 ·Status: RECRUITING ·Phase: NA
-
Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
NCT06059690 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of Stored Tumor Samples in Young Patients With Brain Tumors
NCT00897286 ·Status: TERMINATED
-
A Study of 68Ga-PSMA-11 PET Scans in People With Brain Tumors
NCT06209567 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance
NCT05692635 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluating Tumor Pseudoprogression With FLT-PET and MRI
NCT01105988 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Radiogenomic and Prognosis Analysis in Glioma
NCT04122521 ·Status: UNKNOWN
-
Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma
NCT02359097 ·Status: COMPLETED ·Phase: NA
-
Usefulness of Gadovist-enhanced FLAIR Imaging
NCT05293990 ·Status: COMPLETED ·Phase: NA